MXPA04004743A - Derivados de 2,3-diaril-pirazolidina activos hacia neurotensina. - Google Patents
Derivados de 2,3-diaril-pirazolidina activos hacia neurotensina.Info
- Publication number
- MXPA04004743A MXPA04004743A MXPA04004743A MXPA04004743A MXPA04004743A MX PA04004743 A MXPA04004743 A MX PA04004743A MX PA04004743 A MXPA04004743 A MX PA04004743A MX PA04004743 A MXPA04004743 A MX PA04004743A MX PA04004743 A MXPA04004743 A MX PA04004743A
- Authority
- MX
- Mexico
- Prior art keywords
- neurotensin
- diaryl
- active
- pyrazolidine derivatives
- formula
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/04—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
La invencion describe un grupo de derivados de 2,3-diaril-piparazolidina novedosos que tienen formula (1); ver formula (1) lo simbolos usados en la formula (1) tienen los significados dados en la especificacion; los compuestos tienen la actividad inhibidora en enzimas que degradan el neuropeptido neurotensina y se pueden usar en el tratamiento de afecciones y enfermedades provocadas por disturbios de la transmision mediada por neurotensina.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP02076482 | 2002-03-18 | ||
PCT/EP2003/050064 WO2003078400A1 (en) | 2002-03-18 | 2003-03-17 | Neurotensin active 2,3-diaryl-pyrazolidine derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
MXPA04004743A true MXPA04004743A (es) | 2004-08-02 |
Family
ID=27838122
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MXPA04004743A MXPA04004743A (es) | 2002-03-18 | 2003-03-17 | Derivados de 2,3-diaril-pirazolidina activos hacia neurotensina. |
Country Status (25)
Country | Link |
---|---|
US (1) | US7186741B2 (es) |
EP (1) | EP1487802B1 (es) |
JP (1) | JP4484525B2 (es) |
KR (1) | KR20040106290A (es) |
CN (1) | CN100509788C (es) |
AR (1) | AR038967A1 (es) |
AT (1) | ATE493390T1 (es) |
AU (1) | AU2003219165B2 (es) |
BR (1) | BR0306149A (es) |
CA (1) | CA2462694C (es) |
DE (1) | DE60335525D1 (es) |
DK (1) | DK1487802T3 (es) |
ES (1) | ES2358894T3 (es) |
HK (1) | HK1070646A1 (es) |
HR (1) | HRP20040275A2 (es) |
IL (1) | IL160944A0 (es) |
MX (1) | MXPA04004743A (es) |
NO (1) | NO20044405L (es) |
PL (1) | PL371440A1 (es) |
PT (1) | PT1487802E (es) |
RU (1) | RU2304578C2 (es) |
SI (1) | SI1487802T1 (es) |
UA (1) | UA77775C2 (es) |
WO (1) | WO2003078400A1 (es) |
ZA (1) | ZA200404741B (es) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1801098A1 (en) | 2005-12-16 | 2007-06-27 | Merck Sante | 2-Adamantylurea derivatives as selective 11B-HSD1 inhibitors |
CN102241678B (zh) | 2011-04-26 | 2014-10-29 | 辽宁利锋科技开发有限公司 | 含有脂环结构化合物的抗肿瘤作用与应用 |
BR112016028119A2 (pt) | 2014-06-06 | 2017-08-22 | Res Triangle Inst | Agonistas receptores de apelina (apj) e usos dos mesmos |
EP3386976A1 (en) | 2015-12-09 | 2018-10-17 | Research Triangle Institute, International | Improved apelin receptor (apj) agonists and uses thereof |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3712365A1 (de) * | 1987-04-11 | 1988-10-27 | Hoechst Ag | Neue 2-acylpyrrolidin-derivate, verfahren zu ihrer herstellung, sie enthaltende mittel sowie deren verwendung |
PH27357A (en) * | 1989-09-22 | 1993-06-21 | Fujisawa Pharmaceutical Co | Pyrazole derivatives and pharmaceutical compositions comprising the same |
FR2665898B1 (fr) * | 1990-08-20 | 1994-03-11 | Sanofi | Derives d'amido-3 pyrazole, procede pour leur preparation et compositions pharmaceutiques les contenant. |
FR2711140B1 (fr) * | 1993-10-12 | 1996-01-05 | Sanofi Sa | 1-Naphtylpyrazole-3-carboxamides substitués actifs sur la neurotensine, leur préparation, les compositions pharmaceutiques en contenant. |
-
2003
- 2003-03-13 AR ARP030100880A patent/AR038967A1/es unknown
- 2003-03-17 EP EP03714961A patent/EP1487802B1/en not_active Expired - Lifetime
- 2003-03-17 IL IL16094403A patent/IL160944A0/xx unknown
- 2003-03-17 PL PL03371440A patent/PL371440A1/xx not_active Application Discontinuation
- 2003-03-17 MX MXPA04004743A patent/MXPA04004743A/es active IP Right Grant
- 2003-03-17 SI SI200331966T patent/SI1487802T1/sl unknown
- 2003-03-17 US US10/490,549 patent/US7186741B2/en not_active Expired - Fee Related
- 2003-03-17 AU AU2003219165A patent/AU2003219165B2/en not_active Ceased
- 2003-03-17 RU RU2004114262/04A patent/RU2304578C2/ru not_active IP Right Cessation
- 2003-03-17 PT PT03714961T patent/PT1487802E/pt unknown
- 2003-03-17 JP JP2003576406A patent/JP4484525B2/ja not_active Expired - Fee Related
- 2003-03-17 CA CA2462694A patent/CA2462694C/en not_active Expired - Fee Related
- 2003-03-17 BR BR0306149-3A patent/BR0306149A/pt not_active IP Right Cessation
- 2003-03-17 KR KR10-2004-7014581A patent/KR20040106290A/ko not_active Application Discontinuation
- 2003-03-17 AT AT03714961T patent/ATE493390T1/de active
- 2003-03-17 ES ES03714961T patent/ES2358894T3/es not_active Expired - Lifetime
- 2003-03-17 UA UA20041008453A patent/UA77775C2/uk unknown
- 2003-03-17 DE DE60335525T patent/DE60335525D1/de not_active Expired - Lifetime
- 2003-03-17 CN CNB038015668A patent/CN100509788C/zh not_active Expired - Fee Related
- 2003-03-17 DK DK03714961.4T patent/DK1487802T3/da active
- 2003-03-17 WO PCT/EP2003/050064 patent/WO2003078400A1/en active Application Filing
-
2004
- 2004-03-19 HR HR20040275A patent/HRP20040275A2/hr not_active Application Discontinuation
- 2004-06-15 ZA ZA200404741A patent/ZA200404741B/en unknown
- 2004-10-15 NO NO20044405A patent/NO20044405L/no not_active Application Discontinuation
-
2005
- 2005-04-14 HK HK05103186.3A patent/HK1070646A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
PT1487802E (pt) | 2011-03-11 |
PL371440A1 (en) | 2005-06-13 |
CN1592742A (zh) | 2005-03-09 |
EP1487802A1 (en) | 2004-12-22 |
EP1487802B1 (en) | 2010-12-29 |
WO2003078400A1 (en) | 2003-09-25 |
AU2003219165A1 (en) | 2003-09-29 |
ATE493390T1 (de) | 2011-01-15 |
DK1487802T3 (da) | 2011-04-04 |
UA77775C2 (en) | 2007-01-15 |
NO20044405L (no) | 2004-10-15 |
RU2004114262A (ru) | 2005-09-20 |
US7186741B2 (en) | 2007-03-06 |
AU2003219165B2 (en) | 2008-03-13 |
SI1487802T1 (sl) | 2011-04-29 |
HK1070646A1 (en) | 2005-06-24 |
HRP20040275A2 (en) | 2004-08-31 |
CA2462694A1 (en) | 2003-09-25 |
AR038967A1 (es) | 2005-02-02 |
US20040242493A1 (en) | 2004-12-02 |
CN100509788C (zh) | 2009-07-08 |
BR0306149A (pt) | 2004-10-19 |
IL160944A0 (en) | 2004-08-31 |
ES2358894T3 (es) | 2011-05-16 |
JP2005527528A (ja) | 2005-09-15 |
KR20040106290A (ko) | 2004-12-17 |
JP4484525B2 (ja) | 2010-06-16 |
DE60335525D1 (de) | 2011-02-10 |
RU2304578C2 (ru) | 2007-08-20 |
CA2462694C (en) | 2010-08-10 |
ZA200404741B (en) | 2005-08-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU1074702A (en) | Sulfamides as gamma-secretase inhibitors | |
BG106020A (en) | Inhibitors of impdh enzyme | |
TW200609227A (en) | Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 | |
DE60224189D1 (de) | Dipeptidylpeptidase-hemmer zur behandlung von diabetes | |
YU21702A (sh) | Supstituisani indoli za moduliranje nfkb aktivnosti | |
ATE395912T1 (de) | Dipeptidylpeptidase-hemmer für die behandlung oder prävention von diabetes | |
EP1562897A4 (en) | PHENYL ACARBOXAMIDE AS A BETA SEKRETASE INHIBITOR FOR THE TREATMENT OF ALZHEIMER | |
ATE244717T1 (de) | Inhibitoren des impdh-enzyms | |
SI1567488T1 (sl) | Derivati hidroksietilamina za zdravljenje alzheimerjeve bolezni | |
IL165434A0 (en) | Compounds having DPP-IV inhibitory activity | |
IL148903A0 (en) | Certain alkylene diamine-substituted heterocycles | |
MXPA04005790A (es) | Compuestos y usos de los mismos para reducir la actividad de la lipasa sensible a la hormona. | |
TW200736229A (en) | Substituted 1H-benzimidazole-4-carboxamides are potent PARP inhibitors | |
NO983688L (no) | Serin-protease-inhibitorer | |
WO2003106450A8 (de) | Phenylaminopyrimidine und ihre verwendung als rho-kinase inhibitoren | |
AU8647101A (en) | Compounds having activity as inhibitors of cytochrome p450rai | |
AU1185801A (en) | Novel compounds | |
ATE516027T1 (de) | Orazamid orotat zur vorbeugung von leberschäden | |
MXPA06004308A (es) | Isopentilcarboxanilidas para la lucha contra los microorganismos indeseables. | |
TW200612940A (en) | Substituted tetrahydroisoquinolines as mmp inhibitors, process for their preparation and their use as medicament | |
MXPA04004743A (es) | Derivados de 2,3-diaril-pirazolidina activos hacia neurotensina. | |
SI1244614T1 (en) | Tryptase inhibitors | |
WO2003076429A3 (en) | Azepane derivatives and their use as atk1 inhibitors | |
TW200503672A (en) | 2-aminobenzoyl derivatives | |
RS20050421A (en) | Aminoindazole derivatives and use thereof as kinase inhibitors |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |